AL·Async + video
Telehealth · TN
Tennessee
Tennessee residents can now access GLP-1 medications like semaglutide and tirzepatide through telehealth — from Nashville and Memphis to Knoxville, Chattanooga, and the rural counties in between. Pallas Health pairs you with a board-certified provider licensed in Tennessee who reviews your intake — by secure message in most cases — and if appropriate sends a prescription to a compounding pharmacy that ships to any Tennessee address in a few business days.
- Licensed by
- Tennessee Board of Medical Examiners
- Telehealth
- Async + video
- Compounded semaglutide
- Available
- Compounded tirzepatide
- Available
- Medicaid
- Limited coverage
- Shipping
- 2–3 business days
How telehealth prescribing works in Tennessee
Tennessee permits licensed providers to establish the provider-patient relationship and prescribe non-controlled medications like GLP-1s through telehealth — including asynchronous review of your intake — when the standard of care is met.
Tennessee requires any provider prescribing to a Tennessee resident to hold an active Tennessee medical license. Under Tennessee Board of Medical Examiners telehealth policy, a licensed provider may establish the provider-patient relationship and prescribe non-controlled medications like GLP-1s through telehealth, including synchronous video and, in appropriate cases, asynchronous review, provided the standard of care is met. Every Pallas provider who treats Tennessee patients holds an active Tennessee medical license; depending on your history, a provider may follow up by message, video, or request additional labs before prescribing. GLP-1s are not controlled substances, so Tennessee's separate Controlled Substance Monitoring Database and controlled-substance telemedicine requirements don't add friction here, but our providers still document a complete history, screen for contraindications like personal or family history of medullary thyroid carcinoma, and schedule follow-up visits to monitor response, titrate dose, and manage side effects.
Medicaid & insurance in Tennessee
Limited coverage
TennCare (Tennessee Medicaid) covers GLP-1s for type 2 diabetes with prior authorization. Coverage for weight-management indications is limited. Compounded GLP-1s are not covered.
Pallas is a cash-pay telehealth service. Medicaid and private insurance do not apply to our prescriptions; pricing is flat and disclosed up front.
Simple cash-pay pricing in Tennessee
No insurance, and the same price in every Tennessee ZIP code. You see your full price during intake, before you pay anything.
Compounded plans · provider care included
- Compounded semaglutide$139 first month, then $597 every 12 weeks ($199/mo avg)
- Compounded tirzepatide$179 first month, then $897 every 12 weeks ($299/mo avg)
Your plan price covers your US-licensed provider, ongoing check-ins, dose adjustments, and unlimited care-team messaging — no separate membership fee. Medication ships free and discreet, only if prescribed; refunded in full if a clinician decides treatment isn’t right for you. Cancel anytime. Pay-over-time options are available at checkout.
Brand-name · FDA-approved
FDA-approved Wegovy® and Zepbound® for chronic weight management, plus Ozempic® and Mounjaro® for type 2 diabetes, are available cash-pay from $1,069/mo. Your clinician helps determine which option is appropriate for you.
Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.
Semaglutide vs tirzepatide in Tennessee
Both are once-weekly injections available to Tennessee patients through Pallas, as compounded preparations and as the FDA-approved brand-name products. They work differently: semaglutide activates the GLP-1 receptor, while tirzepatide activates both the GLP-1 and GIP receptors — two of the gut hormones that regulate appetite and fullness.
In SURMOUNT-5, the head-to-head clinical trial of the FDA-approved products, Zepbound® (tirzepatide) produced greater average weight loss than Wegovy® (semaglutide) — roughly 20% versus 14% of body weight over 72 weeks — with broadly similar tolerability. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary.
Cost and track record differ too: compounded semaglutide plans average $199/mo versus $299/mo for tirzepatide (full terms above), and semaglutide has the longer post-market record. Which medication fits your health history, goals, and budget is a decision you make with a clinician licensed in Tennessee — our full semaglutide vs tirzepatide comparison covers the deeper differences.
Cities served in Tennessee
We ship to every ZIP code in Tennessee, including:
- Nashville
- Memphis
- Knoxville
- Chattanooga
- Clarksville
- Murfreesboro
- Franklin
- Jackson
Tennessee GLP-1 questions
Usually no. Tennessee allows a licensed provider to establish the provider-patient relationship and prescribe non-controlled medications like semaglutide through telehealth, including asynchronous review of your intake. Most Tennessee patients complete everything by secure message; a provider may request a brief video visit only if your history calls for it.
TennCare covers certain GLP-1s for FDA-approved diabetes indications with prior authorization. Coverage for weight-management indications is limited. Compounded GLP-1s are not covered. Pallas is a cash-pay telehealth service, so TennCare rules do not affect our pricing.
No. Under Tennessee Board of Medical Examiners rules, the prescribing provider must hold an active Tennessee medical license when treating a patient located in Tennessee. Every Pallas clinician who treats Tennessee patients is individually licensed in Tennessee.
Yes. Compounded tirzepatide prescribed by a Tennessee-licensed provider and dispensed by a U.S. state-licensed compounding pharmacy is available when there is a documented clinical need. Pallas works only with pharmacies that meet state and federal compounding standards.
Compounded semaglutide injection through Pallas is $139 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. That one plan price includes your US-licensed provider, ongoing check-ins, dose adjustments, and unlimited care-team messaging — no separate membership fee. Medication ships free to any Tennessee address, only if a clinician prescribes it, and you are refunded in full if a clinician decides treatment isn't right for you.
Compounded tirzepatide injection through Pallas is $179 for your first month, then $897 every 12 weeks ($299/mo average). Cancel anytime. That one plan price includes your US-licensed provider, ongoing check-ins, dose adjustments, and unlimited care-team messaging — no separate membership fee. Medication ships free to any Tennessee address, only if a clinician prescribes it, and you are refunded in full if a clinician decides treatment isn't right for you.
Yes. FDA-approved Wegovy® and Zepbound® for chronic weight management — plus Ozempic® and Mounjaro® for type 2 diabetes — are available to Tennessee patients cash-pay from $1069/mo; insurance is not billed. Whether a brand-name or compounded medication is appropriate for you is determined by a clinician licensed in Tennessee during intake.
That is a decision you make with your clinician. Semaglutide activates the GLP-1 receptor; tirzepatide activates both the GLP-1 and GIP receptors. In the SURMOUNT-5 head-to-head trial of the FDA-approved products, Zepbound® (tirzepatide) produced greater average weight loss than Wegovy® (semaglutide) — about 20% versus 14% of body weight over 72 weeks. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary. Semaglutide plans cost less and semaglutide has the longer post-market record; a clinician licensed in Tennessee weighs your history, goals, and budget to recommend a starting point.
Start your Tennessee intake